Navigation Links
LegalView Informs Baxter Heparin Patients of New Testing Standards for Blood Thinner Following Deaths From Previous Contamination
Date:3/29/2009

LegalView recently reported on new Baxter Heparin testing standards that are to be implemented this year and will ensure the blood thinner's safety following several deaths after the contaminated drug was used on patients, according to Bloomberg News.The tainted blood thinner was found to have an ingredient that caused the deaths of several and sickened hundreds.

Denver, CO (PRWEB) March 29, 2009 -- LegalView.info, the most comprehensive legal resource available on the Web, recently informed Baxter Heparin patients of the details of new testing standards that the drug will be required to undergo prior to being administered to patients. The standards are part of the U.S. Food and Drug Administration's (FDA) request following an international investigation that the drug was contaminated and which resulted in the alleged deaths of nearly 90 Baxter Heparin patients. The new Baxter Heparin testing standards will include "new equipment to analyze a broader range of impurities" as well as "three identification tests and screening for organic impurities," according to a Bloomberg News report from February 4. Individuals who have previously been a victim to the tainted Baxter Heparin side effects are advised to discuss the legalities of the situation with an experienced Baxter Heparin attorney who can provide a free legal consultation as to the development of a Baxter Heparin class action lawsuit, which may result in the retrieval of monetary compensation.

Baxter's Heparin is made from bovine intestines and liver cells and is used as an injectable blood thinner to ensure blood clots do not form in patients undergoing surgical procedures such as heart surgery or dialysis. Heparin, also heparin sodium, has been used for decades - since the 1930s - among thousands of patients. However, in 2007, the FDA received reports from more than 350 individuals that the drug was causing severe health problems including allergic reaction side effects such as difficulty breathing, vomiting/nausea, increased sweating and a fatal decrease in blood pressure among patients. It was soon discovered that an outside ingredient known as over-sulfated chondroitin sulfate had been added to several batches of the blood thinner from a Chinese manufacturing plant. The discovery prompted a Baxter Heparin recall and intense investigation. Patients who suffered as part of the contaminated Baxter Heparin should discuss the development of a potential Baxter Heparin lawsuit that may result in a patient receiving monetary means as a form of compensation for damages and side effects that occurred as a result of the drug.

In addition to providing the latest news on the Baxter Heparin testing standards, LegalView also offers an extensive library of legal issues to choose from including the latest on mesothelioma treatments as well as news and information on the peanut butter recall and the Fosamax side effects.

Mesothelioma is a rare form of lung cancer caused by the exposure of asbestos fibers and dust. It is common for individuals working in the construction industry to develop this form of lung cancer, which can be fatal, as asbestos was used in an array of construction materials including insulation for homes, offices, apartment complexes, schools, universities and hospitals. Individuals who suffer from the debilitating condition can visit the newly relaunched mesothelioma information portal at mesothelioma treatments, jury verdicts as well as news and information.

The recent peanut butter recall that has infected more than 575 Americans with salmonella bacteria as well as claimed the lives of eight victims is currently being investigated by U.S. government officials regarding alleged falsification of information given by the Peanut Corp. of America to the FDA during its initial investigation into a Blakely, Georgia manufacturing plant. Those who have been affected by the recall are prompted to report their side effects as well as products consumed to officials immediately. Additionally, consulting with a food safety attorney may assist a victim in overcoming any further dangers associated with the poisonings.

Finally, LegalView reports on the recent Fosamax side effects, which have caused patients to not only consider new medications but to discuss the potential for a Fosamax class action lawsuit as well. In January, two medical journals, The New England Journal of Medicine and the Journal of the American Dental Association provided a one-two punch against the drug's manufacturers, Merck and Co., reportedly linking the drug to such side effects as esophageal cancer and jaw bone die-off. Patients of the osteoporosis drug are advised to contact a medical professional to discuss the drug and its alleged dangers.

About LegalView:

Legalview.info is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naudmes. For more information on the accomplishments and track records of Legalview.info's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.info.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2234734.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 31, 2016 , ... Phynd Technologies, Inc. announced recently the signing of three ... and Shore Medical Center – Somers Point, NJ. The new clients range in bed ... the breadth of Phynd’s solution and its interoperability. , Houston Methodist is a leading ...
(Date:5/31/2016)... ... May 31, 2016 , ... In a recent interview ... and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical insurance ... she calls the country’s “modern medical money maelstrom.” , During the interview with ...
(Date:5/31/2016)... ... ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree from ... where he graduated in the top ten percentile of his class. Dr. Ditta has ... has been a member in good standing for thirty years in the American Dental ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Super Powder, a ... to on the go individuals and dedicated athletes, continues to transform the nutritional supplement ... with whey, pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: